Major Changes Ahead for FDA

FDA is juggling momentous changes, including new leadership and the proposed transfer of oversight for therapeutic biotech drugs.

Related Content:

Quality SystemsRegulatory Oversight and CompliancePharmaceutical Technology-11-02-2002

A CDMO’s Role in API Quality

FDA Grants Fast Track Designation to Teva Celiac Disease Candidate

GSK, Spero Therapeutics Oral UTI Treatment Trial Stopped Early for Efficacy